Axillary nodal metastases from carcinoma of unknown primary (CUPAx): A systematic review of published evidence

Breast Cancer Research and Treatment

Volumn 119, Issue 1, 2010, Pages 1-11

  Pentheroudakis, George ^a   Lazaridis, George ^a   Pavlidis, Nicholas ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Axillary metastases; Cancer of unknown primary; Prognosis

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; TAXANE DERIVATIVE;

AXILLARY LYMPH NODE; BIOLOGY; BREAST; CANCER OF UNKNOWN PRIMARY SITE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; COMPARATIVE STUDY; DISEASE CONTROL; FOLLOW UP; HISTOLOGY; HUMAN; INTRADUCTAL CARCINOMA; IRRADIATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE RISK; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AXILLA; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, UNKNOWN PRIMARY; POSTMENOPAUSE; RECEPTOR, ERBB-2; TREATMENT OUTCOME;

EID: 72449134739     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0554-3     Document Type: Review

References (46)

1. N Pavlidis E Briasoulis J Hainsworth FA Greco 2003 Diagnostic and therapeutic management of cancer of unknown primary Eur J Cancer 39 1990 2005 10.1016/S0959-8049(03)00547-1 1:STN:280:DC%2BD3svhslyrsA%3D%3D 12957453 (Pubitemid 37297755)
2. EH Pierce HK Gray MB Dockerty 1973 Surgical significance of isolated axillary adenopathy Surgery 145 104 107
3. EM Copeland CM McBride 1973 Axillary metastases from unknown primary sites Ann Surg 178 25 28 1:STN:280:DyaE3s3hs1Wiuw%3D%3D 4352233
4. D Moher A Liberati J Tetzlaff DG Altman The PRISMA Group 2009 Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement PLoS Med 6 6 e1000097 10.1371/journal.pmed1000097 10.1371/journal.pmed.1000097 19621072
5. HW Owen MB Dockerty HK Gray 1954 Occult carcinoma of breast Surg Gynecol Obstet 98 302 304 1:STN:280:DyaG2c%2Fms1CisQ%3D%3D 13146478
6. L Feuerman JN Attie B Rosenberg 1962 Carcinoma in axillary lymph nodes as an indicator of breast cancer Surg Gynecol Obstet 114 5 8 1:STN:280: DyaF38%2Fjtl2qsg%3D%3D 13892661
7. WT Fitts GC Steiner HT Enterline 1963 Prognosis in occult carcinoma of the breast Am J Surg 106 460 463 10.1016/0002-9610(63)90130-2
8. Haagensen CD (1971) The diagnosis of breast carcinoma. In: Haagensen CD (ed) Diseases of the breast. WB Saunders, Philadelphia, pp 478-502
9. R Ashikari PP Rosen JA Urban T Senoo 1976 Breast cancer presenting as an axillary mass Ann Surg 183 415 417 10.1097/00000658-197604000-00015 1:STN:280:DyaE287otlequg%3D%3D 1267497
10. Z Feigenberg M Zer M Dintsman 1976 Axillary metastases from an unknown primary source. Israel J Med Sci 12 1153 1158 1:STN:280:DyaE2s%2FksFSgtQ%3D%3D
11. P Vezzoni A Balestrazzi P Bignami F Concolino L Gennari U Veronesi 1979 Axillary lymph node metastases from occult carcinoma of the breast Tumori 65 87 91 1:STN:280:DyaE1M7ot1yhtQ%3D%3D 442221
12. MM Kemeny DE Rivera JJ Terz JR Benfield 1986 Occult primary adenocarcinoma with axillary metastases Am J Surg 152 43 47 10.1016/0002- 9610(86)90135-2 1:STN:280:DyaL283ms1ansQ%3D%3D 3728816 (Pubitemid 16069553)
13. SK Bhatia TJ Saclarides TR Witt PD Bonomi KM Anderson SG Economou 1987 Hormone receptor studies in axillary metastases from occult breast cancers Cancer 59 1170 1172 10.1002/1097-0142(19870315)59:6<1170::AID- CNCR2820590623>3.0.CO;2-2 1:STN:280:DyaL2s7jtVGksw%3D%3D 3815292 (Pubitemid 17040399)
14. F Campana A Fourquet MA Ashby X Sastre D Jullien P Schlienger, et al. 1989 Presentation of axillary lymphadenopathy without detectable breast primary: experience at Institut Curie Radiother Oncol 15 321 325 10.1016/0167-8140(89) 90077-7 1:STN:280:DyaK3c%2FhvVGjtg%3D%3D 2552505
15. D Whillis PW Brown A Rodger 1990 Adenocarcinoma from an unknown primary presenting in women with an axillary mass Clin Oncol 2 92 198 10.1016/S0936-6555(05)80166-9
16. PP Rosen M Kimmel 1990 Occult breast carcinoma presenting with axillary lymph node metastases. A follow-up study of 48 patients Hum Pathol 21 518 524 10.1016/0046-8177(90)90008-S 1:STN:280:DyaK3c3kvFyqsg%3D%3D 2338331 (Pubitemid 20165145)
17. N Ellerbroek F Holmes E Singletary H Evans M Oswald M McNeese 1990 Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin Cancer 66 1461 1467 10.1002/1097-0142(19901001)66:7<1461::AID-CNCR2820660704>3.0.CO;2-Z 1:STN:280:DyaK3M%2Fgtlynsw%3D%3D 2207996
18. M Merson S Andreola V Galimberi R Bufalino S Marchini U Veronesi 1992 Breast carcinoma presenting as axillary metastases without evidence of a primary tumour Cancer 70 504 508 10.1002/1097-0142(19920715)70:2<504::AID- CNCR2820700221>3.0.CO;2-T 1:STN:280:DyaK38zhsFWmug%3D%3D 1617600
19. E Svastics P Ronay M Bodo 1993 Occult breast cancer presenting with axillary metastasis Eur J Surg Oncol 19 Suppl 1 575 580 1:STN:280: DyaK2c%2FpsV2lsA%3D%3D 8270047
20. B Van Ooijen M Bontenbal SC Henzen-Logmans PCM Koper 1993 Axillary nodal metastases from an occult primary consistent with breast carcinoma Br J Surg 80 10 1299 1300 10.1002/bjs.1800801026 8242304 (Pubitemid 23313165)
21. T Kyokane S Akashi-Tanaka T Matsui T Fukutomi 1995 Clinicopathological characteristics of non-palpable breast cancer presenting as an axillary mass Breast Cancer 2 105 112 10.1007/BF02966948 11091540
22. B Jackson C Scot-Conner J Moulder 1995 Axillary metastasis from occult breast carcinoma: diagnosis and management Am Surg 61 431 434 1:STN:280:DyaK2M3ltFamug%3D%3D 7733550
23. F Foroudi KW Tiver 2000 Occult breast carcinoma presenting as axillary metastases Int J Radiat Oncol Biol Phys 47 143 147 1:STN:280: DC%2BD3c3itlCisQ%3D%3D 10758316
24. G Vlastos ME Jean AN Mirza NQ Mirza HM Kuerer FC Ames, et al. 2001 Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases Ann Surg Oncol 8 425 431 10.1007/s10434-001-0425-6 1:STN:280:DC%2BD3MzksVGhuw%3D%3D 11407517
25. H Medina-Franco MM Urist 2002 Occult breast carcinoma presenting with axillary lymph node metastases Rev Invest Clin 54 204 208 12183889
26. C Shannon G Walsh F Sapunar R Ahern I Smith 2002 Occult primary breast carcinoma presenting as axillary lymphadenopathy Breast 11 414 418 10.1054/brst.2002.0455 14965705 (Pubitemid 35469500)
27. K Matsuoka S Ohsumi S Takashima T Saeki K Aogi K Mandai 2003 Occult breast carcinoma presenting with axillary lymph node metastases: Follow-up of eleven patients Breast Cancer 10 330 334 10.1007/BF02967653 14634511
28. DK Blanchard DR Farley 2004 Retrospective study of women presenting with axillary metastases from occult breast carcinoma World J Surg 28 535 539 10.1007/s00268-004-7290-y 15366740
29. C Chen SG Orel E Harris MD Schnall BJ Czerniecki LJ Solin 2004 Outcome after treatment of patients with mammographically occult, MRI-detected breast cancer presenting with axillary lymphadenopathy Clin Breast Cancer 5 72 77 10.3816/CBC.2004.n.012 15140289
30. R Varadarajan SB Edge J Yu N Watroba BR Janarthanan 2006 Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis Oncology 71 456 459 10.1159/000107111 17690561
31. JD Iglehart BJ Ferguson WW Shingleton DC Sabiston JS Silva, et al. 1982 An ultrastructural analysis of breast carcinoma presenting as isolated axillary adenopathy Ann Surg 196 8 13 10.1097/00000658-198207000-00002 1:STN:280:DyaL383jtVWgsA%3D%3D 6284071
32. JE Vilcoq R Calle F Ferne F Veith 1982 Conservative treatment of axillary adenopathy due to probable subclinical breast cancer Arch Surg 117 1136 1138 1:STN:280:DyaL383otlagtQ%3D%3D 7115059
33. G Pentheroudakis GE Briasoulis N Pavlidis 2007 Cancer of unknown primary site: missing primary or missing biology? Oncologist 12 418 425 10.1634/theoncologist.12-4-418 1:CAS:528:DC%2BD2sXmtlSitro%3D 17470684 (Pubitemid 46698719)
34. HM Haupt PP Rosen DW Kinne 1985 Breast carcinoma presenting with axillary lymph node metastases Am J Surg Pathol 9 165 175 10.1097/00000478-198503000- 00001 1:STN:280:DyaL2M7ps1GgtA%3D%3D 2986470 (Pubitemid 15045912)
35. EY Ko BK Han JH Shin SS Kang 2007 Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography Korean J Radiol 8 382 389 10.3348/kjr.2007.8.5.382 17923780
36. W DeMartinini C Lehman S Partridge 2008 Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications Acad Radiol 15 408 416 10.1016/j.acra.2007.11.006
37. JA Olson EA Morris KJ Van Zee DC Linehan PI Borgen 2000 MR Imaging facilitates breast conservation for occult breast cancer Ann Surg Oncol 7 411 415 10.1007/s10434-000-0411-4 10894136
38. AA Bader J Tio E Petru M Buchner A Pfahlberg H Volkholz, et al. 2002 T1 breast cancer: identification of patients at low risk of axillary lymph node metastases Breast Cancer Res Treat 76 1 11 17 10.1023/A:1020231300974 1:CAS:528:DC%2BD38XntVKjtLc%3D 12408371 (Pubitemid 35178624)
39. CH Yip NA Taib GH Tan KL Ng BK Yoong WY Choo 2009 Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery? Worl J Surg 33 1 54 57 10.1007/s00268-008-9782-7 1:STN:280: DC%2BD1M%2FhvFKquw%3D%3D
40. AU Buzdar 2009 Role of biologic therapy and chemotherapy in hormone-receptor and HER2-positive breast cancer Ann Oncol 20 993 999 10.1093/annonc/mdn739 1:STN:280:DC%2BD1MzmtlCqug%3D%3D 19150946
41. TM Bennett-Britton AD Purushotham 2009 Understanding breast cancer related lymphedema Surgeon 7 120 124 10.1016/S1479-666X(09)80027-9 1:STN:280:DC%2BD1MzhslentA%3D%3D 19408805
42. M Lacroix TR Toillon G Leclercq 2004 Stable portrait of breast tumours during progression: data from biology, pathology and genetics Endocr Relat Cancer 11 497 522 10.1677/erc.1.00758 1:CAS:528:DC%2BD2cXpsFCms7k%3D 15369451 (Pubitemid 39331280)
43. I Besana-Ciani MJ Greenhall 2008 The importance of margin status after breast conservative surgery and radiotherapy in node-positive patients: a follow-up of 10-15 years Int Semin Surg Oncol 22 5 13
44. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2009) Thresholds for therapies: highlights of the Saint Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. doi: 10.1093/annonc/mdp322
45. LA Newman SE Singletary 2007 Overview of adjuvant systemic therapy in early stage breast cancer Surg Clin North Am 87 499 509 10.1016/j.suc.2007.01. 002 17498540 (Pubitemid 46711114)
46. L Pusztai 2008 Current status of prognostic profiling in breast cancer Oncologist 13 350 360 10.1634/theoncologist.2007-0216 1:CAS:528: DC%2BD1cXmslKksLk%3D 18448548 (Pubitemid 351679913)